<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695199597633</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>Julphar CEO Leaves the Company after 8 Years of Service</TITLE>


<TEXT>
Ras Al Khaimah, United Arab Emirates -<TIMEX3 tid="t1" type="DATE" value="2017-01-29">Sunday</TIMEX3>, <TIMEX3 tid="t2" type="DATE" value="2017-01">January 29th 2017</TIMEX3> [ ME NewsWire ] 
 
Upon expiration of his contract  which <EVENT eid="e1" class="OCCURRENCE">comes</EVENT> in Q2 <TIMEX3 tid="t3" type="DATE" value="2017">2017</TIMEX3>  Dr Ayman Sahli , Chief Executive Officer of Julphar , has <EVENT eid="e2" class="OCCURRENCE">decided</EVENT> not to <EVENT eid="e3" class="OCCURRENCE">renew</EVENT>. The Board <EVENT eid="e4" class="OCCURRENCE">respects</EVENT> his wishes and has <EVENT eid="e5" class="OCCURRENCE">accepted</EVENT> his <EVENT eid="e6" class="OCCURRENCE">decision</EVENT>. Processes are underway to <EVENT eid="e7" class="OCCURRENCE">select</EVENT> his successor. 
 
Commenting on Dr Aymans decision, His Highness Sheikh Faisal Bin Saqr Al Qasimi , Chairman of Julphar, <EVENT eid="e8" class="REPORTING">said</EVENT>: "We appreciate Dr Aymans outstanding service for <TIMEX3 tid="t4" type="DURATION" value="P8Y">more than eight years</TIMEX3>. Despite the challenging market conditions, Dr Ayman <EVENT eid="e9" class="OCCURRENCE">made</EVENT> a major contribution to Julphar and the company has <EVENT eid="e10" class="OCCURRENCE">achieved</EVENT> significant performance improvements and profitability under his leadership. On behalf of the Board, I sincerely <EVENT eid="e11" class="OCCURRENCE">wish</EVENT> him well for <TIMEX3 tid="t5" type="DATE" value="X">the</TIMEX3> future." 
 
"It has been a privilege to have <EVENT eid="e12" class="OCCURRENCE">had</EVENT> the opportunity to <EVENT eid="e13" class="OCCURRENCE">lead</EVENT> Julphar for <TIMEX3 tid="t6" type="DATE" value="200">the last decade</TIMEX3> and I am enormously proud of the accomplishments that have been <EVENT eid="e14" class="OCCURRENCE">made</EVENT>," <EVENT eid="e15" class="REPORTING">said</EVENT> Dr Ayman Sahli. "The company has <EVENT eid="e16" class="OCCURRENCE">played</EVENT> such a positive role in my life. I am grateful for the support I have <EVENT eid="e17" class="OCCURRENCE">received</EVENT> from the Board of Directors and I <EVENT eid="e18" class="I_STATE">express</EVENT> my heartfelt thanks to all employees for their dedication. I am <EVENT eid="e19" class="I_STATE">confident</EVENT> that they will <EVENT eid="e20" class="OCCURRENCE">carry</EVENT> the companys business forward to new heights." 
 
About Julphar 
 
Established in <TIMEX3 tid="t7" type="DATE" value="1980">1980</TIMEX3>, Julphar is the largest generic pharmaceutical manufacturer in Middle East and North Africa, <EVENT eid="e21" class="OCCURRENCE">producing</EVENT> over 200 branded products across its fifteen manufacturing facilities. Julphars mission is to <EVENT eid="e22" class="OCCURRENCE">offer</EVENT> high quality medicines at affordable prices, and its product portfolio includes: Wound, Anemia and Women Care, Adult Primary Care, Pediatric Primary Care, Gastro Care and Pain Management, Cardiopulmonary Care, and Consumer Care. In <TIMEX3 tid="t8" type="DATE" value="2012">2012</TIMEX3> Julphar <EVENT eid="e23" class="OCCURRENCE">launched</EVENT> Julphar Diabetes, a 150 million-dollar Active Pharmaceutical Ingredient (API) manufacturing facility that has the capacity to <EVENT eid="e24" class="OCCURRENCE">produce</EVENT> 1,500 kg of recombinant human insulin and insulin analogues crystals (rDNA). Julphar <EVENT eid="e25" class="OCCURRENCE">employs</EVENT> approximately 3,000 people around the world and registered sales revenue of AED 1.47 billion in <TIMEX3 tid="t9" type="DURATION" value="P1Y">the year</TIMEX3> ending <TIMEX3 tid="t10" type="DATE" value="2015">2015</TIMEX3>. For more information, <EVENT eid="e26" class="OCCURRENCE">please</EVENT> visit http://www.julphar.net . 
   Contacts 
Mehtap Teke 
 
Corporate Communication Manager 
 
M +971-55-1934619, D +971-7-204-5209 
 
Tel +971-7-246-1461, FAX +971-7-246-2462, mehtap.teke@julphar.net 
  
Permalink : http://www.me-newswire.net/news/3266/en
</TEXT>


<MAKEINSTANCE eiid="ie19" eventID="e19" pos="ADJECTIVE" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="NOUN" tense="NONE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie24" eventID="e24" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie25" eventID="e25" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie26" eventID="e26" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="VERB" tense="FUTURE" aspect="NONE" polarity="POS" modality="WOULD" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie22" eventID="e22" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie23" eventID="e23" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />

<TLINK lid="TL1" eventInstanceID="ie17" relatedToEventInstance="ie18" relType="SIMULTANEOUS" />
<TLINK lid="TL0" eventInstanceID="ie12" relatedToEventInstance="ie15" relType="IDENTITY" />
<TLINK lid="TL6" timeID="t8" relatedToEventInstance="ie23" relType="INCLUDES" />
<TLINK lid="TL5" timeID="t3" relatedToEventInstance="ie1" relType="INCLUDES" />
<TLINK lid="TL4" eventInstanceID="ie1" relatedToTime="t1" relType="IS_INCLUDED" />
<TLINK lid="TL3" eventInstanceID="ie1" relatedToTime="t3" relType="IS_INCLUDED" />
<TLINK lid="TL2" eventInstanceID="ie1" relatedToTime="t2" relType="IS_INCLUDED" />
</TimeML>
